 | Marinus Pharmaceuticals, Inc. | |||
| NGM : MRNS || Location: United States | ||||
$1.41-0.03 (-1.91%) |
0.39 M | 1.4 - 1.46 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.475 M |
| March 15, 2024 | 3.573 M |
| Feb. 29, 2024 | 3.427 M |
| Feb. 15, 2024 | 3.570 M |
| Jan. 31, 2024 | 3.619 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.64 | -0.74 | -16.46% |
| 09/30/2023 | -0.67 | -0.61 | 9.48% |
| 06/30/2023 | -0.73 | -0.61 | 16.56% |
| 03/31/2023 | -0.74 | -0.67 | 9.13% |
| 12/31/2022 | -0.71 | -0.76 | -6.95% |
MRNS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 54.931M | Shares Float | 42.763M |
| Short Float | 3.475M | Market Cap | 79.10M |
| Institution ownership | 98.62% | Insider ownership | 0.966% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.63 | Forward EPS | -1.41 |